A news item in the June 26, 2001, issue of BioWorld Today said Ariad Pharmaceuticals Inc., of Cambridge, Mass., had $22.7 million in cash and cash equivalents as of March 31, 2001. The company also had $12.3 million in marketable securities.

Editor¿s Note: The clarification has been made in BioWorld Online.

No Comments